Skip to main content
Clinical Trials/KCT0005793
KCT0005793
Completed
未知

Evaluation of the efficacy and safety of 3D printing porous titanium cage with Non-Window type versus Window type in lumbar interbody fusion: A prospective, randomized, multicenter trial

Chung-Ang Univerisity Hospital0 sites70 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Chung-Ang Univerisity Hospital
Enrollment
70
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 6, 2023
Last Updated
2 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Chung-Ang Univerisity Hospital

Eligibility Criteria

Inclusion Criteria

  • ? Patients with degenerative spinal diseases of the lumbar spine and need single\-segment interbody fusion because there is no symptom improvement even after conservative treatment for at least 6 weeks
  • ? Patients with confirmed spinal degenerative diseases related to symptoms by X\-ray and MRI examination
  • ? Patients with no communication problems in conducting and conducting clinical research
  • ? Patients who participate in the test, observe treatment and procedures, and are willing to visit the hospital for all follow\-up evaluation
  • ? Patients who voluntarily agree to participate in clinical research and are willing to comply with the subject matters

Exclusion Criteria

  • ? Patients under 18 years of age or over 80 years of age
  • ? Patients unable to perform spinal surgery under general anesthesia due to severe heart, lung disease, liver disease, and kidney function decline
  • ? Patients scheduled for surgery due to spinal infection or tumor within 12 months from registration
  • ? Those who take drugs that may affect bone union immediately before or after surgery (eg, steroids, parathyroid hormone, etc.)
  • ? Patients whose remaining life expectancy is less than 1 year
  • ? Patients in the age group who are pregnant and planning to become pregnant during the study period
  • ? Patients who are not suitable for this clinical study in the opinion of the researcher or who may increase the risk associated with participation in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials